Perioperative Management and Outcome of Catecholamine-Induced Takotsubo and Dilated Cardiomyopathy in Pheochromocytoma and Paraganglioma
- 5 February 2025
- journal article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (5) , 1275-1281
Abstract
No abstract availableKeywords
Funding Information
- Peking Union Medical College Hospital
This publication has 32 references indexed in Scilit:
- Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approachesThe Lancet, 2023
- Phenoxybenzamine is no longer the standard agent used for alpha blockade before adrenalectomy for pheochromocytoma: A national study of 552 patientsSurgery, 2022
- Comparison of Preoperative Alpha-blockade for Resection of Paraganglioma and PheochromocytomaEndocrine Practice, 2022
- Perioperative outcomes of pheochromocytoma/paraganglioma surgery preceded by Takotsubo-like cardiomyopathySurgery, 2022
- Predictors of hemodynamic instability in patients with pheochromocytoma and paragangliomaJournal of Surgical Oncology, 2020
- Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?Hormone and Metabolic Research, 2018
- Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single centerEndocrine, 2018
- Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literatureInternational Journal of Cardiology, 2017
- Perioperative Management of Pheochromocytoma and Catecholamine-Induced Dilated Cardiomyopathy in a Pediatric PatientPediatric Cardiology, 2012
- Regional wall motion abnormalities in patients with pheochromocytomaHypertension Research, 2012